Table 2.
Statistical analysis was performed using one-way analysis of variance (ANOVA) followed by Duncan post-hoc test with SPSS 15.0 for modified neurological severity scores (mNSS).The data are presented as the mean±SD. Rats with hUCMSC+G-CSF treatment had a more significant improvement on (mNSS) in 5 and 6 weeks compared to other treatment group (P< 0.01).
| Week |
W1 | W2 | W3 | W4 | W5 | W6 |
|---|---|---|---|---|---|---|
| Group | ||||||
| TBI+PBS | 10.3±0.483 | 9.4±0.699 | 8.6±0.516 | 7.1±0.567 | 6.1±0.567 | 5.5±0.527 |
| TBI+Brdu | 10.3±0.483 | 9.5±0.707 | 8.6±0.516 | 7.1±0.567 | 6.1±0.567 | 5.5±0.527 |
| TBI+G-CSF | 9.3±0.483 | 8.3±0.483 | 6.8±0.788 | 5.9±0.567 | 4.9±0.567 | 4.2±0.421 |
| TBI+HUCMSc | 9.2±0.632 | 8.2±0.918 | 6.6±0.699 | 5.7±0.674 | 4.7±0.948 | 3.9±0.737 |
| TBI+HUCMSc+G-CSF | 9±0.66 | 7.9±0.576 | 6.3±0.674 | 5.5±0.527 | 3.9±0.567 | 2.8±0.421 |